RecruitingNCT04694924

Prospective Prostate Cancer and Patient-reported Outcomes Registry

Promoting Quality of Care: a Prospective Cohort Study of Localized and Locally Advanced Prostate Cancer Patients


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

5,000 participants

Start Date

Oct 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients diagnosed with localized or locally advanced prostate cancer.


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study collecting data on quality-of-life outcomes for men with localized or locally advanced prostate cancer across multiple treatment options, to understand how different treatments affect patients' day-to-day lives from the patient's own perspective. **You may be eligible if...** - You have a confirmed diagnosis of localized or locally advanced prostate cancer (confirmed by pathology) - You speak, read, and understand Dutch, French, or English - You have not previously been treated for prostate cancer - You are willing to sign an informed consent form **You may NOT be eligible if...** - You have already received treatment for prostate cancer - You have dementia, a psychiatric condition, or other issues that prevent you from completing questionnaires or following the study protocol - You are incarcerated or otherwise legally restricted Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERstandard of care

No other procedures than those performed during the usual care for prostate cancer patients will be done. No study medication will be provided as part of participation. Clinical outcomes will be reported via predefined electronic forms, integrated into the electronic health record (EHR). Patient-reported outcomes will be collected electronically. All treatment decisions will be made at the discretion of the investigator or treating physician.


Locations(4)

AZ Sint-Blasius

Dendermonde, Oost-Vlaanderen, Belgium

University Hospitals Leuven

Leuven, Vlaams-Brabant, Belgium

AZ Sint-Jan Brugge

Bruges, West-Vlaanderen, Belgium

AZ Groeninge Kortrijk

Kortrijk, West-Vlaanderen, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04694924


Related Trials